Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complication by cardiogenic shock

Korean Journal of Internal Medicine

Volumn 20, Issue 1, 2005, Pages 8-14

  Bae, Eun Hui ^a   Lim, Sang Yup ^a   Jeong, Myung Ho ^a   Park, Hyung Wook ^a   Lim, Ji Hyun ^a   Hong, Young Joon ^a   Kim, Weon ^a   Kim, Ju Han ^a   Cho, Jeong Gwan ^a   Ahn, Young Keun ^a   Park, Jong Chun ^a   Suh, Soon Pal ^a   Ahn, Byoung Hee ^a   Kim, Sang Hyung ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Coronary diseases; Myocardial infarction; Prognosis; Shock

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; KOREA; LEFT CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; SENESCENCE; STROKE; UNIVERSITY HOSPITAL;

EID: 21144452531     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2005.20.1.8     Document Type: Article

References (30)

1. National Stational Office, Republic of Korea. Annual report on the cause of death statistics (based on vital registration). 1998
2. Garrahy PJ, Hanzlowa MJ, Forman S, Rogers WJ. Has thrombolytic improved survival from cardiogenic shock? Circulation 80(Suppl II):II623, 1989
3. Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J 141:65-72, 2001
4. Webb JG, Sanbom TA, Sleeper LA, Carere RG, Buller CE, Slater JN, Baran KW, Koller PT, Talley JD, Porway M, Hochman JS. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial registry. Am Heart J 141:964-970, 2001
5. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined. J Am Coll Cardiol 36:959-969, 2000
6. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 330:1724-1739, 1994
7. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879-888, 1996
8. TIMI Study Group. The Thrombolysis in Myocardial Infaction (TIMI) Trial. N Engl J Med 312:932-936, 1985
9. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340:1162-1168, 1999
10. Hasdai D, Holmes DR Jr, Topol EJ, Berger PB, Criger DA, Hochman JS, Bates ER, Vahanian A, Armstrong PW, Wilcox R, Ohman EM, Califf RM. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Eur Heart J 20:128-135, 1999
11. Hong YJ, Jeong MH, Lee SH, Park OY, Jeong WK, Lee SR, Kim W, Rhew JY, Lee SH, Ahn YK, Cho JG, Ahn BH, Park JC, Kim SH, Kang JC. The long-term clinical outcomes after rescue percutaneous coronary intervention in patients with acute myocardial infarction. J Interv Cardiol 16:209-216, 2003
12. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C, Braunwald E. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol 14:40-46, 1989
13. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med 94:265-273, 1993
14. Frid DJ, Young S, Woodlief LH, Kereiakes DJ, George BS, Bates ER. Undercompensation: the role of the non-infarct related zone in the pathogenesis of cardiogenic shock. Circulation 82:III430, 1990
15. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36:1063-1070, 2000
16. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly. Circulation 108:166-170, 2003
17. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369, 2003
18. Genest J, Pedersen TR. Prevention of cardiovascular ischemic events: high-risk and secondary prevention. Circulation 107:2059-2065, 2003
19. Hong YJ, Jeong MH, Park HW, Lee SH, Park OY, Jeong WK, Lee SR, Yum JH, Kim W, Kim JH, Rhew JY, Ahn YK, Cho JG, Suh SP, Ahn BH, Kim SH, Park JC, Kang JC. The role of C-reactive protein on long-term clinical outcomes in patients with acute myocardial infarction. Korean Med J 61:606-615, 2001
20. The TRACE Study Group. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. Am J Cardiol 73:44c-50c, 1994
21. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341:625-634, 1999
22. TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet 358:951-957, 2001
23. Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, Budaj A, Lopez de Sa E, Lopez-Sendon J. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 90:838-842, 2002
24. Ammann P, Straumann E, Naegeli B, Schuiki E, Frielingsdorf J, Gerber A, Bertel O. Long-term results after acute percutaneous transluminal coronary angioplasty in acute myocardial infarction and cardiogenic shock. Int J Cardiol 82:127-131, 2002
25. Dauerman HL, Goldberg RJ, Malinski M, Yarzebski J, Lessard D, Gore JM. Outcomes and early revascularization for patients more than 65 years of age with cardiogenic shock. Am J Cardiol 87:844-848, 2001
26. Edep ME, Brown DL. Effect of early revascularization on mortality from cardiogenic shock complicating acute myocardial infarction in California. Am J Cardiol 85:1185-1188, 2000
27. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction. Am Heart J 141:933-939, 2001
28. Brodie BR, Stuckey TD, Hansen C, Muncy D. Intraaortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 84:18-23, 1999
29. Pi K, Block PC, Warner MG, Diethrich EB. Major determinants of survival and nonsurvival of intraaortic balloon pumping. Am Heart J 130:849-853, 1995
30. Castelli P, Condemi A, Munari M, Savi C, Carro C, Vanelli P. Intra-aortic balloon counterpulsation: outcome in cardiac surgical patients. J Cardiothorac Vasc Anesth 15:700-703, 2001